|
1
|
Lee K and Nelson CM: New insights into the
regulation of epithelial-mesenchymal transition and tissue
fibrosis. Int Rev Cell Mol Biol. 294:171–221. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Desai S, Laskar S and Pandey BN: Autocrine
IL-8 and VEGF mediate epithelial-mesenchymal transition and
invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer
cells. Cell Signal. 25:1780–1791. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nieto MA: The ins and outs of the
epithelial to mesenchymal transition in health and disease. Annu
Rev Cell Dev Biol. 27:347–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li XJ, Peng LX, Shao JY, Lu WH, Zhang JX,
Chen S, Chen ZY, Xiang YQ, Bao YN, Zheng FJ, et al: As an
independent unfavorable prognostic factor, IL-8 promotes metastasis
of nasopharyngeal carcinoma through induction of
epithelial-mesenchymal transition and activation of AKT signaling.
Carcinogenesis. 33:1302–1309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mathias RA, Gopal SK and Simpson RJ:
Contribution of cells undergoing epithelial-mesenchymal transition
to the tumour microenvironment. J Proteomics. 78:545–57. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Palena C, Hamilton DH and Fernando RI:
Influence of IL-8 on the epithelial-mesenchymal transition and the
tumor microenvironment. Future Oncol. 8:713–722. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Malmberg KJ and Ljunggren HG: Escape from
immune- and nonimmune-mediated tumor surveillance. Semin Cancer
Biol. 16:16–31. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Koch AE, Polverini PJ, Kunkel SL, Harlow
LA, DiPietro LA, Elner VM, Elner SG and Strieter RM: Interleukin-8
as a macrophage-derived mediator of angiogenesis. Science.
258:1798–1801. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bhusari PA and Khairnar KB: Greater
omental pancake tumour due to metastasis of ovarian cancer-a
cadaveric study. J Clin Diagn Res. 8:142–143. 2014.PubMed/NCBI
|
|
10
|
Yu J, Ren X, Chen Y, Liu P, Wei X, Li H,
Ying G, Chen K, Winkler H and Hao X: Dysfunctional activation of
neurotensin/IL-8 pathway in hepatocellular carcinoma is associated
with increased inflammatory response in microenvironment, more
epithelial mesenchymal transition in cancer and worse prognosis in
patients. PLoS One. 8:e560692013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fernando RI, Castillo MD, Litzinger M,
Hamilton DH and Palena C: IL-8 signaling plays a critical role in
the epithelial-mesenchymal transition of human carcinoma cells.
Cancer Res. 71:5296–5306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Islam SS, Mokhtari RB, El Hout Y, Azadi
MA, Alauddin M, Yeger H and Farhat WA: TGF-β1 induces EMT
reprogramming of porcine bladder urothelial cells into collagen
producing fibroblasts-like cells in a Smad2/Smad3-dependent manner.
J Cell Commun Signal. 8:39–58. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bose SK, Meyer K, Di Bisceglie AM, Ray RB
and Ray R: Hepatitis C virus induces epithelial-mesenchymal
transition in primary human hepatocytes. J Virol. 86:13621–13628.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Radisky DC, Levy DD, Littlepage LE, Liu H,
Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, et
al: Rac1b and reactive oxygen species mediate MMP-3-induced EMT and
genomic instability. Nature. 436:123–127. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ye Y, Liu P, Wang Y, Li H, Wei F, Cheng Y,
Han L and Yu J: Neurotensin, a novel messenger to cross-link
inflammation and tumor invasion via epithelial-mesenchymal
transition pathway. Int Rev Immunol. 35:340–350. 2016.PubMed/NCBI
|
|
16
|
Zhou N, Lu F, Liu C, Xu K, Huang J, Yu D
and Bi L: IL-8 induces the epithelial-mesenchymal transition of
renal cell carcinoma cells through the activation of AKT signaling.
Oncol Lett. 12:1915–1920. 2016.PubMed/NCBI
|
|
17
|
Nieto MA: Epithelial plasticity: A common
theme in embryonic and cancer cells. Science. 342:12348502013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hugo H, Ackland ML, Blick T, Lawrence MG,
Clements JA, Williams ED and Thompson EW: Epithelial-mesenchymal
and mesenchymal-epithelial transitions in carcinoma progression. J
Cell Physiol. 213:374–383. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim MJ, Doh II, Bae GY, Cha HJ and Cho YH:
Cell-matrix adhesion characterization using multiple shear stress
zones in single stepwise microchannel. Appl Phys Lett.
105:0837012016. View Article : Google Scholar
|
|
21
|
Rokavec M, Öner MG, Li H, Jackstadt R,
Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, et
al: IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated
colorectal cancer invasion and metastasis. J Clin Invest.
124:1853–1867. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Berx G, Raspé E, Christofori G, Thiery JP
and Sleeman JP: Pre-EMTing metastasis? Recapitulation of
morphogenetic processes in cancer. Clin Exp Metastasis. 24:587–597.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ota I, Li XY, Hu Y and Weiss SJ: Induction
of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration
program in cancer cells by Snail1. Proc Natl Acad Sci USA. 106:pp.
20318–20323. 2009; View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sarrio D, Rodriguez-Pinilla SM, Hardisson
D, Cano A, Moreno-Bueno G and Palacios J: Epithelial-mesenchymal
transition in breast cancer relates to the basal-like phenotype.
Cancer Res. 68:989–997. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Desai S, Kumar A, Laskar S and Pandey BN:
Cytokine profile of conditioned medium from human tumor cell lines
after acute and fractionated doses of gamma radiation and its
effect on survival of bystander tumor cells. Cytokine. 61:54–62.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dudley AT, Lyons KM and Robertson EJ: A
requirement for bone morphogenetic protein-7 during development of
the mammalian kidney and eye. Genes Dev. 9:2795–2807. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Illman SA, Lehti K, Keski-Oja J and Lohi
J: Epilysin (MMP-28) induces TGF-beta mediated epithelial to
mesenchymal transition in lung carcinoma cells. J Cell Science.
119:3856–3865. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiong M, Jiang L, Zhou Y, Qiu W, Fang L,
Tan R, Wen P and Yang J: The miR-200 family regulates
TGF-β1-induced renal tubular epithelial to mesenchymal transition
through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J
Physiol Renal Physiol. 302:F369–F379. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park GB, Kim D, Kim YS, Kim S, Lee HK,
Yang JW and Hur DY: The Epstein-Barr virus causes
epithelial-mesenchymal transition in human corneal epithelial cells
via Syk/src and Akt/Erk signaling pathways. Invest Ophthalmol Vis
Sci. 55:1770–1779. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo CB, Wang S, Deng C, Zhang DL, Wang FL
and Jin XQ: Relationship between matrix metalloproteinase 2 and
lung cancer progression. Mol Diagn Ther. 11:183–192. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gregory AD and Houghton AM:
Tumor-associated neutrophils: New targets for cancer therapy.
Cancer Res. 71:2411–2416. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fang S, Yu L, Mei H, Yang J, Gao T, Cheng
A, Guo W, Xia K and Liu G: Cisplatin promotes mesenchymal-like
characteristics in osteosarcoma through Snail. Oncol Lett.
12:5007–5014. 2016.PubMed/NCBI
|
|
34
|
Alba-Castellon L, Olivera-Salguero R,
Mestre-Farrera A, Pena R, Herrera M, Bonilla F, Casal JI, Baulida
J, Peña C and García de Herreros A: Snail1-dependent activation of
cancer-associated fibroblast controls epithelial tumor cell
invasion and metastasis. Cancer Res. 76:6205–6217. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Haraguchi M, Sato M and Ozawa M:
CRISPR/Cas9n-mediated deletion of the Snail 1Gene (SNAI1) reveals
its role in regulating cell morphology, cell-cell interactions and
gene expression in ovarian cancer (RMG-1) cells. PLoS One.
10:e01322602015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hwang WL, Yang MH, Tsai ML, Lan HY, Su SH,
Chang SC, Teng HW, Yang SH, Lan YT, Chiou SH and Wang HW: SNAIL
regulates interleukin-8 expression, stem cell-like activity and
tumorigenicity of human colorectal carcinoma cells.
Gastroenterology. 141:279–291, 291.e1-e5. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Leong KG, Niessen K, Kulic I, Raouf A,
Eaves C, Pollet I and Karsan A: Jagged1-mediated Notch activation
induces epithelial-to-mesenchymal transition through Slug-induced
repression of E-cadherin. J Exp Med. 204:2935–2948. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Niessen K, Fu Y, Chang L, Hoodless PA,
McFadden D and Karsan A: Slug is a direct Notch target required for
initiation of cardiac cushion cellularization. J Cell Biol.
182:315–325. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sahlgren C, Gustafsson MV, Jin S,
Poellinger L and Lendahl UL: Notch signaling mediates
hypoxia-induced tumor cell migration and invasion. Proc Natl Acad
Sci USA. 105:pp. 6392–6397. 2008; View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Timmerman LA, Grego-Bessa J, Raya A,
Bertrén E, Pérez-Pomares JM, Díez J, Aranda S, Palomo S, McCormick
F, Izpisúa-Belmonte JC and de la Pompa JL: Notch promotes
epithelial-mesenchymal transition during cardiac development and
oncogenic transformation. Genes Dev. 18:99–115. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yanagawa J, Walser TC, Zhu LX, Hong L,
Fishbein MC, Mah V, Chia D, Goodglick L, Elashoff DA, Luo J, et al:
Snail promotes CXCR2 ligand-dependent tumor progression in
non-small cell lung carcinoma. Clin Cancer Res. 15:6820–6829. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu ZC, Chen XH, Song HX, Wang HS, Zhang
G, Wang H, Chen DY, Fang R, Liu H, Cai SH and Du J: Snail regulated
by PKC/GSK-3β pathway is crucial for EGF-induced
epithelial-mesenchymal transition (EMT) of cancer cells. Cell
Tissue Res. 358:491–502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gras B, Jacqueroud L, Wierinckx A, Lamblot
C, Fauvet F, Lachuer J, Puisieux A and Ansieau S: Snail family
members unequally trigger EMT and thereby differ in their ability
to promote the neoplastic transformation of mammary epithelial
cells. PLoS One. 9:e922542014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wettstein G, Bellaye PS, Kolb M, Hammann
A, Crestani B, Soler P, Marchal-Somme J, Hazoume A, Gauldie J,
Gunther A, et al: Inhibition of HSP27 blocks fibrosis development
and EMT features by promoting Snail degradation. FASEB J.
27:1549–1560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zheng H and Kang Y: Multilayer control of
the EMT master regulators. Oncogene. 33:1755–1763. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang J, Zhou Y and Yang Y: CCR7 pathway
induces epithelial-mesenchymal transition through up-regulation of
Snail signaling in gastric cancer. Med Oncol. 32:4672015.PubMed/NCBI
|
|
47
|
Sullivan NJ, Sasser AK, Axel AE, Vesuna F,
Raman V, Ramirez N, Oberyszyn TM and Hall BM: Interleukin-6 induces
an epithelial-mesenchymal transition phenotype in human breast
cancer cells. Oncogene. 28:2940–2947. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gonzalez-Moreno O, Lecanda J, Green JE,
Segura V, Catena R, Serrano D and Calvo A: VEGF elicits
epithelial-mesenchymal transition (EMT) in prostate intraepithelial
neoplasia (PIN)-like cells via an autocrine loop. Exp Cell Res.
316:554–567. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mironchik Y, Winnard PT Jr, Vesuna F, Kato
Y, Wildes F, Pathak AP, Kominsky S, Artemov D, Bhujwalla Z, van
Diest P, et al: Twist overexpression induces in vivo angiogenesis
and correlates with chromosomal instability in breast cancer.
Cancer Res. 65:10801–10809. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang Y, Yao X, Ge J, Hu F and Zhao Y: Can
vascular endothelial growth factor and microvessel density be used
as prognostic biomarkers for colorectal cancer? A systematic review
and meta-analysis. ScientificWorldJournal.
2014:1027362014.PubMed/NCBI
|
|
51
|
Maxwell PJ, Coulter J, Walker SM,
McKechnie M, Neisen J, McCabe N, Kennedy RD, Salto-Tellez M,
Albanese C and Waugh DJ: Potentiation of inflammatory CXCL8
signalling sustains cell survival in PTEN-deficient prostate
carcinoma. Eur Urol. 64:177–88. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Murphy C, McGurk M, Pettigrew J,
Santinelli A, Mazzucchelli R, Johnston PG, Montironi R and Waugh
DJ: Nonapical and cytoplasmic expression of interleukin-8, CXCR1,
and CXCR2 correlates with cell proliferation and microvessel
density in prostate cancer. Clin Cancer Res. 11:4117–4127. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ogura M, Takeuchi H, Kawakubo H, Nishi T,
Fukuda K, Nakamura R, Takahashi T, Wada N, Saikawa Y, Omori T, et
al: Clinical significance of CXCL-8/CXCR-2 network in esophageal
squamous cell carcinoma. Surgery. 154:512–520. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Uzunoglu FG, Yavari N, Bohn BA, Nentwich
MF, Reeh M, Pantel K, Perez D, Tsui TY, Bockhorn M, Mann O, et al:
C-X-C motif receptor 2, endostatin and proteinase-activated
receptor 1 polymorphisms as prognostic factors in NSCLC. Lung
Cancer. 81:123–129. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Pecot CV, Rupaimoole R, Yang D, Akbani R,
Ivan C, Lu C, Wu S, Han HD, Shah MY, Rodriguez-Aguayo C, et al:
Tumour angiogenesis regulation by the miR-200 family. Nat Commun.
4:24272013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Mendonca MA, Souto FO, Micheli DC,
Alves-Filho JC, Cunha FQ, Murta EF and Tavares-Murta BM: Mechanisms
affecting neutrophil migration capacity in breast cancer patients
before and after chemotherapy. Cancer Chemother Pharmacol.
73:317–324. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Merritt WM, Lin YG, Spannuth WA, Fletcher
MS, Kamat AA, Han LY, Landen CN, Jennings N, de Geest K, Langley
RR, et al: Effect of interleukin-8 gene silencing with
liposome-encapsulated small interfering RNA on ovarian cancer cell
growth. J Natl Cancer Inst. 100:359–372. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Papassava P, Gorgoulis VG, Papaevangeliou
D, Vlahopoulos S, van Dam H and Zoumpourlis V: Overexpression of
activating transcription factor-2 is required for tumor growth and
progression in mouse skin tumors. Cancer Res. 64:8573–8584. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Tindberg N, Porsmyr-Palmertz M and Simi A:
Contribution of MAP kinase pathways to the activation of ATF-2 in
human neuroblastoma cells. Neurochem Res. 25:527–531. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ricote M, Garcia-Tunon I, Bethencourt F,
Fraile B, Onsurbe P, Paniagua R and Royuela M: The p38 transduction
pathway in prostatic neoplasia. J Pathol. 208:401–407. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Eliopoulos AG, Gallagher NJ, Blake SM,
Dawson CW and Young LS: Activation of the p38 mitogen-activated
protein kinase pathway by Epstein-Barr virus-encoded latent
membrane protein 1 coregulates interleukin-6 and interleukin-8
production. J Biol Chem. 274:16085–16096. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wang L, Tang C, Cao H, Li K, Pang X, Zhong
L, Dang W, Tang H, Huang Y, Wei L, et al: Activation of IL-8 via
PI3K/Akt-dependent pathway is involved in leptin-mediated
epithelial-mesenchymal transition in human breast cancer cells.
Cancer Biol Ther. 16:1220–1230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Hill R, Calvopina JH, Kim C, Wang Y,
Dawson DW, Donahue TR, Dry S and Wu H: PTEN loss accelerates
KrasG12D-induced pancreatic cancer development. Cancer Res.
70:7114–7124. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yan W, Han P, Zhou Z, Tu W, Liao J, Li P,
Liu M, Tian D and Fu Y: Netrin-1 induces epithelial-mesenchymal
transition and promotes hepatocellular carcinoma invasiveness. Dig
Dis Sci. 59:1213–1221. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Song J, Feng L, Zhong R, Xia Z, Zhang L,
Cui L, Yan H, Jia X and Zhang Z: Icariside II inhibits the EMT of
NSCLC cells in inflammatory microenvironment via down-regulation of
Akt/NF-κB signaling pathway. Mol Carcinog. 56:36–48. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Voorzanger N, Touitou R, Garcia E,
Delecluse HJ, Rousset F, Joab I, Favrot MC and Blay JY: Interleukin
(IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma
cells and act as cooperative growth factors. Cancer Res.
56:5499–5505. 1996.PubMed/NCBI
|
|
67
|
Carpenter RL, Paw I, Dewhirst MW and Lo
HW: Akt phosphorylates and activates HSF-1 independent of heat
shock, leading to Slug overexpression and epithelial-mesenchymal
transition (EMT) of HER2-overexpressing breast cancer cells.
Oncogene. 34:546–557. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Baranwal S and Alahari SK: Molecular
mechanisms controlling E-cadherin expression in breast cancer.
Biochem Biophys Res Commun. 384:6–11. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Moon HG, Zheng Y, An CH, Kim YK and Jin Y:
CCN1 secretion induced by cigarette smoking extracts augments IL-8
release from bronchial epithelial cells. PLoS One. 8:e681992013.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan
J, Wu J and Li M: MicroRNA-374a activates Wnt/β-catenin signaling
to promote breast cancer metastasis. J Clin Invest. 123:566–579.
2013.PubMed/NCBI
|
|
71
|
Zappulli V, de Cecco S, Trez D, Caliari D,
Aresu L and Castagnaro M: Immunohistochemical expression of
E-cadherin and β-catenin in feline mammary tumours. J Comp Pathol.
147:161–170. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Ahn SH, Park H, Ahn YH, Kim S, Cho MS,
Kang JL and Choi YH: Necrotic cells influence migration and
invasion of glioblastoma via NF-κB/AP-1-mediated IL-8 regulation.
Sci Rep. 6:245522016. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Cheng XS, Li YF, Tan J, Sun B, Xiao YC,
Fang XB, Zhang XF, Li Q, Dong JH, Li M, et al: CCL20 and CXCL8
synergize to promote progression and poor survival outcome in
patients with colorectal cancer by collaborative induction of the
epithelial-mesenchymal transition. Cancer Lett. 348:77–87. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Zhao ZW, Wang YX, Lv X, Nie YM and Wu J:
Shear stress promotes epithelial-mesenchymal transition of
laryngeal cancer cells by inducing IL-8/CXCR1-NF-Kappa B axis. J
Invest Med. 62:S802014.
|
|
75
|
Choi SH, Kwon OJ, Park JY, Kim DY, Ahn SH,
Kim SU, Ro SW, Kim KS, Park JH, Kim S, et al: Inhibition of tumour
angiogenesis and growth by small hairpin HIF-1α and IL-8 in
hepatocellular carcinoma. Liver Int. 34:632–642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wu S, Shang H, Cui L, Zhang Z, Zhang Y, Li
Y, Wu J, Li RK and Xie J: Targeted blockade of interleukin-8
abrogates its promotion of cervical cancer growth and metastasis.
Mol Cell Biochem. 375:69–79. 2013.PubMed/NCBI
|
|
77
|
Pine SR, Mechanic LE, Enewold L,
Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso
NE and Harris CC: Increased levels of circulating interleukin 6,
interleukin 8, C-reactive protein, and risk of lung cancer. J Natl
Cancer Inst. 103:1112–1122. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Xie K: Interleukin-8 and human cancer
biology. Cytokine Growth Factor Rev. 12:375–391. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Bates RC, DeLeo MJ III and Mercurio AM:
The epithelial-mesenchymal transition of colon carcinoma involves
expression of IL-8 and CXCR-1-mediated chemotaxis. Exp Cell Res.
299:315–324. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Yang JR, Pan TJ, Yang H, Wang T, Liu W,
Liu B and Qian WH: Kindlin-2 promotes invasiveness of prostate
cancer cells via NF-κB-dependent upregulation of matrix
metalloproteinases. Gene. 576:571–576. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zucchini-Pascal N, Peyre L and Rahmani R:
Crosstalk between beta-catenin and snail in the induction of
epithelial to mesenchymal transition in hepatocarcinoma: Role of
the ERK1/2 pathway. Int J Mol Sci. 14:20768–20792. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Zhao J, Zhang ZR, Zhao N, Ma BA and Fan
QY: VEGF silencing inhibits human osteosarcoma angiogenesis and
promotes cell apoptosis via PI3K/AKT signaling pathway. Int J Clin
Exp Med. 8:12411–12417. 2015.PubMed/NCBI
|
|
83
|
Matsumoto G, Hirohata R, Hayashi K,
Sugimoto Y, Kotani E, Shimabukuro J, Hirano T, Nakajima Y, Kawamata
S and Mori H: Control of angiogenesis by VEGF and
endostatin-encapsulated protein microcrystals and inhibition of
tumor angiogenesis. Biomaterials. 35:1326–1333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Shen Y, Wang D and Wang X: Role of CCR2
and IL-8 in acute lung injury: A new mechanism and therapeutic
target. Expert Rev Respir Med. 5:107–114. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Skov L, Beurskens FJ, Zachariae CO,
Reitamo S, Teeling J, Satijn D, Knudsen KM, Boot EP, Hudson D,
Baadsgaard O, et al: IL-8 as antibody therapeutic target in
inflammatory diseases: Reduction of clinical activity in
palmoplantar pustulosis. J Immunol. 181:669–679. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Hatfield KJ, Olsnes AM, Gjertsen BT and
Bruserud Ø: Antiangiogenic therapy in acute myelogenous leukemia:
Targeting of vascular endothelial growth factor and interleukin 8
as possible antileukemic strategies. Curr Cancer Drug Targets.
5:229–248. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Li WH, Qiu Y, Zhang HQ, Liu Y, You JF,
Tian XX and Fang WG: P2Y2 receptor promotes cell invasion and
metastasis in prostate cancer cells. Br J Cancer. 109:1666–1675.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Waugh DJ and Wilson C: The interleukin-8
pathway in cancer. Clin Cancer Res. 14:6735–6741. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Schadendorf D, Möller A, Algermissen B,
Worm M, Sticherling M and Czarnetzki BM: IL-8 produced by human
malignant melanoma cells in vitro is an essential autocrine growth
factor. J Immunol. 151:2667–2675. 1993.PubMed/NCBI
|
|
90
|
de Larco JE, Wuertz BR, Rosner KA,
Erickson SA, Gamache DE, Manivel JC and Furcht LT: A potential role
for interleukin-8 in the metastatic phenotype of breast carcinoma
cells. Am J Pathol. 158:639–646. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Maxwell PJ, Gallagher R, Seaton A, Wilson
C, Scullin P, Pettigrew J, Stratford IJ, Williams KJ, Johnston PG
and Waugh DJ: HIF-1 and NF-kappaB-mediated upregulation of CXCR1
and CXCR2 expression promotes cell survival in hypoxic prostate
cancer cells. Oncogene. 26:7333–7345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Lattanzio L, Tonissi F, Torta I, Gianello
L, Russi E, Milano G, Merlano M and Lo Nigro C: Role of IL-8
induced angiogenesis in uveal melanoma. Invest New Drugs.
31:1107–1114. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Li KC, Huang YH, Ho CY, Chu CY, Cha ST,
Tsai HH, Ko JY, Chang CC and Tan CT: The role of IL-8 in the
SDF-1α/CXCR4-induced angiogenesis of laryngeal and hypopharyngeal
squamous cell carcinoma. Oral Oncol. 48:507–515. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Shen XH, Xu SJ, Jin CY, Ding F, Zhou YC
and Fu GS: Interleukin-8 prevents oxidative stress-induced human
endothelial cell senescence via telomerase activation. Int
Immunopharmacol. 16:261–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Rofstad EK and Halsør EF: Vascular
endothelial growth factor, interleukin 8, platelet-derived
endothelial cell growth factor, and basic fibroblast growth factor
promote angiogenesis and metastasis in human melanoma xenografts.
Cancer Res. 60:4932–4938. 2000.PubMed/NCBI
|
|
96
|
Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu
C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB,
Bottsford-Miller J, et al: Stress effects on FosB- and
interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. J
Biol Chem. 285:35462–3547070. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Ginestier C, Liu S, Diebel ME, Korkaya H,
Luo M, Brown M, Wicinski J, Cabaud O, Charafe-Jauffret E, Birnbaum
D, et al: CXCR1 blockade selectively targets human breast cancer
stem cells in vitro and in xenografts. J Clin Invest. 120:485–497.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Sparmann A and Bar-Sagi D: Ras-induced
interleukin-8 expression plays a critical role in tumor growth and
angiogenesis. Cancer Cell. 6:447–458. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Yin J, Zeng F, Wu N, Kang K, Yang Z and
Yang H: Interleukin-8 promotes human ovarian cancer cell migration
by epithelial-mesenchymal transition induction in vitro. Clin
Transl Oncol. 17:365–370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Kim SW, Hayashi M, Lo JF, Fearns C, Xiang
R, Lazennec G, Yang Y and Lee JD: Tid1 negatively regulates the
migratory potential of cancer cells by inhibiting the production of
interleukin-8. Cancer Res. 65:8784–8791. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Luca M, Huang S, Gershenwald JE, Singh RK,
Reich R and Bar-Eli M: Expression of interleukin-8 by human
melanoma cells up-regulates MMP-2 activity and increases tumor
growth and metastasis. Am J Pathol. 151:1105–1113. 1997.PubMed/NCBI
|
|
102
|
Sheridan C, Kishimoto H, Fuchs RK,
Mehrotra S, Bhat-Nakshatri P, Turner CH, Badve R Jr, Goulet S and
Nakshatri H: CD44+/CD24- breast cancer cells exhibit enhanced
invasive properties: An early step necessary for metastasis. Breast
Cancer Res. 8:R592006. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Haro A, Yano T, Kohno M, Yoshida T, Koga
T, Okamoto T, Takenoyama M and Maehara Y: Expression of Brachyury
gene is a significant prognostic factor for primary lung carcinoma.
Ann Surg Oncol. 20 Suppl 3:S509–S516. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Choi J, Song N, Han S, Chung S, Sung H,
Lee JY, Jung S, Park SK, Yoo KY, Han W, et al: The associations
between immunity-related genes and breast cancer prognosis in
Korean women. PLoS One. 9:e1035932014. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Hanker LC, Rody A, Holtrich U, Pusztai L,
Ruckhaeberle E, Liedtke C, Ahr A, Heinrich TM, Sänger N, Becker S
and Karn T: Prognostic evaluation of the B cell/IL-8 metagene in
different intrinsic breast cancer subtypes. Breast Cancer Res
Treat. 137:407–16. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Reitter EM, Ay C, Kaider A, Pirker R,
Zielinski C, Zlabinger G and Pabinger I: Interleukin levels and
their potential association with venous thromboembolism and
survival in cancer patients. Clin Exp Immunol. 177:253–260. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Wang S, Wu X, Zhang J, Chen Y, Xu J, Xia
X, He S, Qiang F, Li A, Shu Y, et al: CHIP functions as a novel
suppressor of tumour angiogenesis with prognostic significance in
human gastric cancer. Gut. 62:496–508. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Manna S, Singha B, Phyo SA, Gatla HR,
Chang TP, Sanacora S, Ramaswami S and Vancurova I: Proteasome
inhibition by bortezomib increases IL-8 expression in
androgen-independent prostate cancer cells: The role of IKKα. J
Immunol. 191:2837–2846. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Han J, Bae SY, Oh SJ, Lee J, Lee JH, Lee
HC, Lee SK, Kil WH, Kim SW, Nam SJ, et al: Zerumbone suppresses
IL-1β-induced cell migration and invasion by inhibiting IL-8 and
MMP-3 expression in human triple-negative breast cancer cells.
Phytother Res. 28:1654–1660. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Epanchintsev A, Shyamsunder P, Verma RS
and Lyakhovich A: IL-6, IL-8, MMP-2, MMP-9 are overexpressed in
Fanconi anemia cells through a NF-κB/TNF-α dependent mechanism. Mol
Carcinog. 54:1686–1699. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Dong P, Xiong Y, Watari H, Hanley SJ,
Konno Y, Ihira K, Yamada T, Kudo M, Yue J and Sakuragi N: MiR-137
and miR-34a directly target Snail and inhibit EMT, invasion and
sphere-forming ability of ovarian cancer cells. J Exp Clin Cancer
Res. 35:1322016. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Meng J, Zhang XT, Liu XL, Fan L, Li C, Sun
Y, Liang XH, Wang JB, Mei QB, Zhang F and Zhang T: WSTF promotes
proliferation and invasion of lung cancer cells by inducing EMT via
PI3K/Akt and IL-6/STAT3 signaling pathways. Cell Signal.
28:1673–1682. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Huang T, Chen Z and Fang L: Curcumin
inhibits LPS-induced EMT through downregulation of NF-κB-snail
signaling in breast cancer cells. Oncol Rep. 29:117–124.
2013.PubMed/NCBI
|
|
114
|
Zhang Z, Chen H, Xu C, Song L, Huang L,
Lai Y, Wang Y, Chen H, Gu D, Ren L and Yao Q: Curcumin inhibits
tumor epithelial-mesenchymal transition by downregulating the Wnt
signaling pathway and upregulating NKD2 expression in colon cancer
cells. Oncol Rep. 35:2615–2623. 2016.PubMed/NCBI
|
